Vijay Karwal
Direktor/Vorstandsmitglied bei MEGA LIFESCIENCES
Profil
Vijay Karwal is currently an Independent Director at Mega Lifesciences Public Co. Ltd.
and the Chief Financial Officer at AffaMed Therapeutics (HK) Ltd.
Prior to his current roles, he worked as a Managing Director at Nomura International (Hong Kong) Ltd.
from 2018 to 2021, as the Chief Development Officer at Davita, Inc. (Singapore) from 2016 to 2017, and at ABN AMRO Bank NV (Old) from 2004 to 2011.
He graduated from the University of Groningen.
Aktive Positionen von Vijay Karwal
| Unternehmen | Position | Beginn |
|---|---|---|
| MEGA LIFESCIENCES | Direktor/Vorstandsmitglied | 13.05.2021 |
AffaMed Therapeutics (HK) Ltd.
 AffaMed Therapeutics (HK) Ltd. BiotechnologyHealth Technology Part of AffaMed Therapeutics, AffaMed Therapeutics (HK) Ltd. develops and commercializes ophthalmology, neurological and psychiatric products. The company is based in Hong Kong, Hong Kong. | Finanzdirektor/CFO | 01.05.2021 |
Ehemalige bekannte Positionen von Vijay Karwal
| Unternehmen | Position | Ende |
|---|---|---|
Nomura International (Hong Kong) Ltd.
 Nomura International (Hong Kong) Ltd. Investment Banks/BrokersFinance Nomura International (Hong Kong) Ltd. (Nomura International HK) is the brokerage subsidiary of Nomura Asia Pacific Holdings Co. Ltd., which is ultimately-owned by Nomura Holdings, Inc. (TYO: 8604) in Japan. Headquartered in Hong Kong, the firm’s global markets team offers research, sales and trading of global securities to a diverse range of clients globally, including institutional investors, financial institutions, corporates, financial sponsors and government entities. Nomura International HK operates a truly integrated, cross-asset platform which includes research, sales and trading in equities, currencies, rates and credit in cash and derivative products. | Corporate Officer/Principal | 01.05.2021 |
| Davita, Inc. (Singapore) | Corporate Officer/Principal | 01.11.2017 |
Ausbildung von Vijay Karwal
| University of Groningen | Graduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| MEGA LIFESCIENCES | Health Technology |
| Private Unternehmen | 3 |
|---|---|
AffaMed Therapeutics (HK) Ltd.
AffaMed Therapeutics (HK) Ltd. BiotechnologyHealth Technology Part of AffaMed Therapeutics, AffaMed Therapeutics (HK) Ltd. develops and commercializes ophthalmology, neurological and psychiatric products. The company is based in Hong Kong, Hong Kong. | Health Technology |
| Davita, Inc. (Singapore) | |
Nomura International (Hong Kong) Ltd.
Nomura International (Hong Kong) Ltd. Investment Banks/BrokersFinance Nomura International (Hong Kong) Ltd. (Nomura International HK) is the brokerage subsidiary of Nomura Asia Pacific Holdings Co. Ltd., which is ultimately-owned by Nomura Holdings, Inc. (TYO: 8604) in Japan. Headquartered in Hong Kong, the firm’s global markets team offers research, sales and trading of global securities to a diverse range of clients globally, including institutional investors, financial institutions, corporates, financial sponsors and government entities. Nomura International HK operates a truly integrated, cross-asset platform which includes research, sales and trading in equities, currencies, rates and credit in cash and derivative products. | Finance |
